The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments
Open accessAbstract
Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT) conducted a revision of the 2009 guidelines by updating the evidence and recommendations. The scope of the 2016 guidelines remains the management of major depressive disorder (MDD) in adults, with a target audience of psychiatrists and other mental health professionals. Methods: Using the question-answer format, we conducted a systematic literature search focusing on systematic reviews and meta-analyses. Evidence was graded using CANMAT-defined criteria for level of evidence. Recommendations for lines of treatment were based on the quality of evidence and clinical expert consensus. “Complementary and Alternative Medicine Treatments” is the fifth of six sections of the 2016 guidelines. Results: Evidence-informed responses were developed for 12 questions for 2 broad categories of complementary and alternative medicine (CAM) interventions: 1) physical and meditative treatments (light therapy, sleep deprivation, exercise, yoga, and acupuncture) and 2) natural health products (St. John’s wort, omega-3 fatty acids; S-adenosyl-L-methionine [SAM-e], dehydroepiandrosterone, folate, Crocus sativus, and others). Recommendations were based on available data on efficacy, tolerability, and safety. Conclusions: For MDD of mild to moderate severity, exercise, light therapy, St. John’s wort, omega-3 fatty acids, SAM-e, and yoga are recommended as first- or second-line treatments. Adjunctive exercise and adjunctive St. John’s wort are second-line recommendations for moderate to severe MDD. Other physical treatments and natural health products have less evidence but may be considered as third-line treatments. CAM treatments are generally well tolerated. Caveats include methodological limitations of studies and paucity of data on long-term outcomes and drug interactions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Light therapy, consisting of daily exposure to bright artificial light, is an evidence-based nonpharmacological treatment for seasonal and nonseasonal major depressive disorder (MDD) that has a low side effect burden and can be used by patients alongside other treatments.”
From Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials (2020) · cites this paper as [14]
In the citing paper
“Light therapy is a recommended first- or second-line treatment for MDD in clinical guidelines 14 based on many clinical studies and meta-analyses. 15,16”
From Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials (2020) · cites this paper as [14]
In the citing paper
“The contrasting statements conveyed by international treatment guidelines preclude drawing definitive conclusions regarding the role of exercise as a treatment for non-severe depression.”
In the citing paper
“Specifically, the use of exercise as an alternative treatment for non-severe depression is endorsed by several treatment guidelines (EPA in Europe, CANMAT in Canada, NICE in the UK and RANZCP in Australia).19–22”
In the citing paper
“Our findings align with the recommendations provided by European, Canadian, Australian and UK treatment guidelines supporting the use of exercise as an alternative treatment for non-severe depression.19–22”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,566
Cooney, G. M., Dwan, K., Greig, C. A., Lawlor, D. A., Rimer, J., Waugh, F. R., McMurdo, M., & Mead, G. E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004366.pub6 · Cited by 1,834
Physical Activity and the Prevention of Depression
Mammen, G., & Faulkner, G. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.08.001 · Cited by 1,122 · cited 1×
“A systematic review of large populationbased, prospective studies suggested that participation in physical activity may also prevent the onset of depression.(47) Further research is therefore needed to assess the long-term benefits of exercise for depression.”
BackgroundSelf-citationTrends in use of complementary and alternative medicine by US adults: 1997-2002.
Tindle, H. A., Davis, R. B., Phillips, R. S., & Eisenberg, D. M. (2005) · PubMed · Cited by 1,099
Cooney, G. M., Dwan, K., Greig, C. A., Lawlor, D. A., Rimer, J., Waugh, F. R., McMurdo, M., & Mead, G. E. (2014) · Advances in Psychiatric Treatment · doi:10.1192/apt.20.1.2 · Cited by 895
Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., Keck, P. E., Marangell, L. B., Richardson, A. J., Lake, J., et al. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1217 · Cited by 709 · cited 1×
“Patients on anticoagulant and antiplatelet medications may also require additional monitoring.(76) Manic induction has been reported in a few cases, although not in bipolar depressed patients.”
BackgroundCramer, H., Lauche, R., Langhorst, J., & Dobos, G. (2013) · Depression and Anxiety · doi:10.1002/da.22166 · Cited by 708 · cited 2×
“Limitations of yoga studies include low quality of RCTs, variability in practice parameters and physical/mental health of participants, as well as difficulties with suitable control conditions.(49) Long-term efficacy and safety data are also lacking.”
BackgroundRosenbaum, S., Tiedemann, A., Sherrington, C., Curtis, J., & Ward, P. B. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08765 · Cited by 692 · cited 2×
“For moderate to severe MDD, 1 meta-analysis (20 trials, N 1⁄4 1298) found exercise to be superior to control conditions.(44) Some methodological challenges, including suitability of control conditions, adequacy of blinding and self-selection bias, may limit interpretation of results.”
BackgroundBrown, R. P., & Gerbarg, P. L. (2005) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2005.11.189 · Cited by 655 · cited 1×
“The proposed neurobiological mechanisms for its benefit include increased turnover of dopamine and gamma-aminobutyric acid (GABA) levels in specific brain regions, regulation of the hypothalamic-pituitaryadrenal axis,(49) and normalization of heart rate variability.(50) The duration of yoga interventions varies, avera…”
BackgroundBauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632 · cited 1×
“Light therapy is generally well tolerated,(17) with common side effects being eye strain, headache, agitation, nausea, and sedation.(19) Since 2009, 2 meta-analyses,(16,20) 4 systematic reviews(17,19,21,22) and 3 RCTs(23-25) have been generally confirmatory of recommendations in the 2009 guidelines (see Suppl.”
Background
Research works printed but not linked: 11
- Tindle HA, 2005, Altern Ther Health Med, 11, 42
- Coelho HF, 2007, Altern Ther Health Med, 13, 40
- Güleç M, 2011, Bull Clin Psychopharm, 21, S89
- Lam RW, 2015, JAMA Psychiatry, 18, 1
- 10.1176/appi.ajp.2015.14101293 · DOI · Paper page
- Cooney GM, 2013, Cochrane Database Syst Rev, 9, CD004366
- Smith CA, 2010, Cochrane Database Syst Rev, 1, CD004046
- Carpenter DJ., 2011, Altern Med Rev, 16, 17
- Appleton KM, 2015, Cochrane Database Syst Rev, 11, CD004692
- Ginsberg LD, 2011, Innov Clin Neurosci, 8, 19
- Dwyer AV, 2011, Altern Med Rev, 16, 40
Cited by
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Dambrova, M., Makrecka-Kuka, M., Kuka, J., Vilskersts, R., Nordberg, D., Attwood, M. M., Smesny, S., Sen, Z. D., Guo, A. C., Oler, E., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000408 · Cited by 507
“However, the most studied condition associated with acetylcarnitine supplementation is major depressive disorder (MDD), which has been assessed in multiple clinical trials (see Section V).”
MethodInfluentialMorres, I. D., Hatzigeorgiadis, A., Stathi, A., Comoutos, N., Arpin-Cribbie, C., Krommidas, C., & Theodorakis, Y. (2019) · Depression and Anxiety · doi:10.1002/da.22842 · Cited by 350
The Role of Exercise in Preventing and Treating Depression
Schuch, F. B., & Stubbs, B. (2019) · Current Sports Medicine Reports · doi:10.1249/jsr.0000000000000620 · Cited by 264
Sarris, J., Ravindran, A., Yatham, L. N., Marx, W., Rucklidge, J. J., McIntyre, R. S., Akhondzadeh, S., Benedetti, F., Caneo, C., Cramer, H., et al. (2022) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.2013041 · Cited by 216
Self-citationSassarini, D. J. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.09.004 · Cited by 207
Metadata
- Authors
- Ravindran, A. V., Balneaves, L. G., Faulkner, G., Ortiz, A., McIntosh, D., Morehouse, R. L., Ravindran, L., Yatham, L. N., Kennedy, S. H., Lam, R. W., MacQueen, G. M., Milev, R. V., Parikh, S. V., & the CANMAT Depression Work Group
- Affiliations
- University of Toronto (CA)
- University of British Columbia (CA)
- University of Ottawa (CA)
- Dalhousie University (CA)
- University of Calgary (CA)
- Queen's University (CA)
- ORCID
- Venue
- The Canadian Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2016-08-11
- Volume
- 61
- Issue
- 9
- Pages
- 576-587
- ISSN
- 0706-7437 (ISSN-L)
- 1497-0015
- PMC
- PMC4994794
- OpenAlex
- W2493003628
- Cited by
- 337
- References
- 105
- Citations by year
- 2026: 18 · 2025: 36 · 2024: 43 · 2023: 28 · 2022: 43 · 2021: 39 · 2020: 40 · 2019: 33 · 2018: 30 · 2017: 21 · 2016: 6
- FWCI
- 24.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- The Canadian Journal of Psychiatry (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- major depressive disorder, adults, complementary and alternative medicine, natural health products, Hypericum perforatum, omega-3 fatty acids, S-adenosylmethionine, dehydroepiandrosterone, folic acid, saffron, phototherapy, sleep deprivation, physical activity, yoga, acupuncture, adjunctive therapy, treatment guidelines
- MeSH terms
- Biological Products, Canada, Major Depressive Disorder, Exercise Therapy, Humans, Phototherapy, Sleep Deprivation, Acupuncture Therapy, Practice Guidelines as Topic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. https://app.cochat.ai/papers/10.1177/0706743716660290
- The paper
- Ravindran, A. V., Balneaves, L. G., Faulkner, G., Ortiz, A., McIntosh, D., Morehouse, R. L., Ravindran, L., Yatham, L. N., Kennedy, S. H., Lam, R. W., MacQueen, G. M., Milev, R. V., Parikh, S. V., & the CANMAT Depression Work Group. (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments. The Canadian Journal of Psychiatry. https://doi.org/10.1177/0706743716660290
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.